As a recurrent endometrial cancer survivor (pMMR) currently trying to maintain an active lifestyle with side effects of pembrolizumab/lenvatinib treatment, I am encouraged by your contributors knowledge and dedication to research. Unfortunately, I have no scientific training so will be studying the transcript over and over. Many thanks.
Try selinexor clinical trials if your p53 is unmutated. Selinexor is a weekly oral drug used for Maintenance therapy in wt p53 ec patients. Especially for pMMR population, it shows 39.5 months vs 5.9 months PFS in recent published literature.
